SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-075630
Filing Date
2024-06-20
Accepted
2024-06-20 16:30:11
Documents
11
Period of Report
2024-06-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20240617.htm   iXBRL 8-K 43040
  Complete submission text file 0000950170-24-075630.txt   157884

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20240617.xsd EX-101.SCH 24848
14 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20240617_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

IRS No.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 241056704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)